24 May 2013
Keywords: roche, avastin, launched, uk, rcc, bevacizumab, been
Article | 28 January 2008
Roche's Avastin (bevacizumab) has been launched in the UK for the first-line treatment of patients with advanced renal cell cancer ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.